Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
111.53
-2.74 (-2.40%)
At close: Sep 6, 2024, 4:00 PM
114.00
+2.47 (2.21%)
After-hours: Sep 6, 2024, 4:10 PM EDT
Masimo Revenue
Masimo had revenue of $496.30M in the quarter ending June 29, 2024, with 9.01% growth. This brings the company's revenue in the last twelve months to $2.02B, down -7.76% year-over-year. In the year 2023, Masimo had annual revenue of $2.05B with 0.60% growth.
Revenue (ttm)
$2.02B
Revenue Growth
-7.76%
P/S Ratio
2.93
Revenue / Employee
$530,763
Employees
3,800
Market Cap
5.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 30, 2023 | 2.05B | 12.30M | 0.60% |
| Dec 31, 2022 | 2.04B | 796.60M | 64.28% |
| Jan 1, 2022 | 1.24B | 95.50M | 8.35% |
| Jan 2, 2021 | 1.14B | 205.86M | 21.95% |
| Dec 28, 2019 | 937.84M | 79.55M | 9.27% |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Jan 2, 2016 | Pro | Pro | Pro |
| Jan 3, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.30B |
| Jazz Pharmaceuticals | 3.91B |
| R1 RCM | 2.38B |
| Stevanato Group | 1.17B |
| Inspire Medical Systems | 705.71M |
| Doximity | 493.63M |
| Blueprint Medicines | 362.80M |
| BridgeBio Pharma | 219.12M |
MASI News
- 1 day ago - Masimo CEO shared confidential information with investor ahead of public release, court filing shows - CNBC
- 2 days ago - Politan Provides Update on Why Masimo Shareholders Should Support Urgently Needed Board Change at Company's 2024 AGM - Business Wire
- 5 days ago - Masimo Urges Stockholders to Vote “FOR” Only Masimo's Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card Today - Business Wire
- 10 days ago - Masimo to Present in Wells Fargo Healthcare Conference - Business Wire
- 10 days ago - Masimo, under activist pressure, subpoenaed two top proxy advisors for private investor communications - CNBC
- 12 days ago - Masimo Partners with March of Dimes to Help Parents with Babies in the NICU Make the Transition from Hospital to Home - Business Wire
- 13 days ago - Masimo Has the Right Leadership and Strategy to Drive Long-Term Value Creation - Business Wire
- 13 days ago - Masimo SET® Pulse Oximetry: Superior Performance, Worldwide Presence, Immeasurable Impact - Business Wire